Gentium
Nasdaq) biopharmaceutical company specializing in the discovery, research, development and manufacture of.
Launch date
Share price
$6.03 GNT
Company register number CO0240386
Villa Guardia Lombardy (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 23.8m | 6.5m | 10.3m | 6.4m | 10.5m |
| % growth | - | (73 %) | 58 % | (38 %) | 64 % |
| Profit | 23.2m | 5.7m | 9.7m | 5.7m | 9.6m |
| % profit margin | 97 % | 88 % | 94 % | 90 % | 92 % |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
N/A | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Gentium
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.